Literature DB >> 18922462

Phosphoproteomics: unraveling the signaling web.

Paul H Huang1, Forest M White.   

Abstract

In recent years, phosphoproteomic technologies have increased our understanding of cellular signaling networks. Here, we frame recent phosphoproteomics-based advances in the context of the DNA damage response and ErbB receptor family signaling and offer a perspective on how the molecular insights arising from the integration of such proteomic approaches might be used for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922462      PMCID: PMC2754874          DOI: 10.1016/j.molcel.2008.09.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  16 in total

Review 1.  A biological approach to computational models of proteomic networks.

Authors:  Kevin A Janes; Douglas A Lauffenburger
Journal:  Curr Opin Chem Biol       Date:  2006-01-06       Impact factor: 8.822

2.  Actin microfilament aggregation induced by withaferin A is mediated by annexin II.

Authors:  Ryan R Falsey; Marilyn T Marron; G M Kamal B Gunaherath; Nikhil Shirahatti; Daruka Mahadevan; A A Leslie Gunatilaka; Luke Whitesell
Journal:  Nat Chem Biol       Date:  2005-12-11       Impact factor: 15.040

3.  Profiling of UV-induced ATM/ATR signaling pathways.

Authors:  Matthew P Stokes; John Rush; Joan Macneill; Jian Min Ren; Kam Sprott; Julie Nardone; Vicky Yang; Sean A Beausoleil; Steven P Gygi; Mark Livingstone; Hui Zhang; Roberto D Polakiewicz; Michael J Comb
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

4.  ATR regulates hexavalent chromium-induced S-phase checkpoint through phosphorylation of SMC1.

Authors:  Timothy P Wakeman; Bo Xu
Journal:  Mutat Res       Date:  2006-07-27       Impact factor: 2.433

5.  Control of MAPK signalling: from complexity to what really matters.

Authors:  Jorrit J Hornberg; Bernd Binder; Frank J Bruggeman; Birgit Schoeberl; Reinhart Heinrich; Hans V Westerhoff
Journal:  Oncogene       Date:  2005-08-25       Impact factor: 9.867

Review 6.  ERBB receptors and cancer: the complexity of targeted inhibitors.

Authors:  Nancy E Hynes; Heidi A Lane
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

7.  Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

Authors:  M A Cobleigh; C L Vogel; D Tripathy; N J Robert; S Scholl; L Fehrenbacher; J M Wolter; V Paton; S Shak; G Lieberman; D J Slamon
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

8.  Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.

Authors:  Jayne M Stommel; Alec C Kimmelman; Haoqiang Ying; Roustem Nabioullin; Aditya H Ponugoti; Ruprecht Wiedemeyer; Alexander H Stegh; James E Bradner; Keith L Ligon; Cameron Brennan; Lynda Chin; Ronald A DePinho
Journal:  Science       Date:  2007-09-13       Impact factor: 47.728

9.  Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.

Authors:  Paul H Huang; Akitake Mukasa; Rudy Bonavia; Ryan A Flynn; Zachary E Brewer; Webster K Cavenee; Frank B Furnari; Forest M White
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

10.  Effects of HER2 overexpression on cell signaling networks governing proliferation and migration.

Authors:  Alejandro Wolf-Yadlin; Neil Kumar; Yi Zhang; Sampsa Hautaniemi; Muhammad Zaman; Hyung-Do Kim; Viara Grantcharova; Douglas A Lauffenburger; Forest M White
Journal:  Mol Syst Biol       Date:  2006-10-03       Impact factor: 11.429

View more
  29 in total

1.  Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome.

Authors:  Tiannan Guo; Sze Sing Lee; Wai Har Ng; Yi Zhu; Chee Sian Gan; Jiang Zhu; Haixia Wang; Shiang Huang; Siu Kwan Sze; Oi Lian Kon
Journal:  Cell Mol Life Sci       Date:  2010-10-16       Impact factor: 9.261

Review 2.  Proteomics: a pragmatic perspective.

Authors:  Parag Mallick; Bernhard Kuster
Journal:  Nat Biotechnol       Date:  2010-07-09       Impact factor: 54.908

3.  MASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics.

Authors:  Wenxuan Cai; Huseyin Guner; Zachery R Gregorich; Albert J Chen; Serife Ayaz-Guner; Ying Peng; Santosh G Valeja; Xiaowen Liu; Ying Ge
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

4.  Single-step enrichment by Ti4+-IMAC and label-free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution.

Authors:  Erik L de Graaf; Piero Giansanti; A F Maarten Altelaar; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2014-05-21       Impact factor: 5.911

5.  Phosphoproteomic analysis of protein phosphorylation networks in Tetrahymena thermophila, a model single-celled organism.

Authors:  Miao Tian; Xiulan Chen; Qian Xiong; Jie Xiong; Chuanle Xiao; Feng Ge; Fuquan Yang; Wei Miao
Journal:  Mol Cell Proteomics       Date:  2013-11-07       Impact factor: 5.911

6.  Quantitative analysis of receptor tyrosine kinase-effector coupling at functionally relevant stimulus levels.

Authors:  Simin Li; Devayani Bhave; Jennifer M Chow; Thomas V Riera; Sandra Schlee; Simone Rauch; Mariya Atanasova; Richard L Cate; Adrian Whitty
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 7.  Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer.

Authors:  Simon Vyse; Annie Howitt; Paul H Huang
Journal:  J Mol Biol       Date:  2017-05-03       Impact factor: 5.469

8.  Towards the systematic discovery of signal transduction networks using phosphorylation dynamics data.

Authors:  Haruna Imamura; Nozomu Yachie; Rintaro Saito; Yasushi Ishihama; Masaru Tomita
Journal:  BMC Bioinformatics       Date:  2010-05-07       Impact factor: 3.169

Review 9.  Exploiting receptor tyrosine kinase co-activation for cancer therapy.

Authors:  Aik-Choon Tan; Simon Vyse; Paul H Huang
Journal:  Drug Discov Today       Date:  2016-07-21       Impact factor: 7.851

10.  Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.

Authors:  Cuiping Pan; Jesper V Olsen; Henrik Daub; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2009-08-03       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.